Cargando…
Targeting BCL-2 in Cancer: Advances, Challenges, and Perspectives
SIMPLE SUMMARY: Apoptosis, a programmed form of cell death, represents the main mechanism by which cells die. Such phenomenon is highly regulated by the BCL-2 family of proteins, which includes both pro-apoptotic and pro-survival proteins. The decision whether cells live or die is tightly controlled...
Autores principales: | Hafezi, Shirin, Rahmani, Mohamed |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8001391/ https://www.ncbi.nlm.nih.gov/pubmed/33799470 http://dx.doi.org/10.3390/cancers13061292 |
Ejemplares similares
-
Targeting BCL-2 regulated apoptosis in cancer
por: Campbell, Kirsteen J., et al.
Publicado: (2018) -
Small molecules in targeted cancer therapy: advances, challenges, and future perspectives
por: Zhong, Lei, et al.
Publicado: (2021) -
Targeting Bcl2 in cancer
por: Chen, Guo, et al.
Publicado: (2015) -
The BCL-2 arbiters of apoptosis and their growing role as cancer targets
por: Adams, Jerry M, et al.
Publicado: (2018) -
BCL-2 protein family: attractive targets for cancer therapy
por: Kaloni, Deeksha, et al.
Publicado: (2022)